Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety

Peer Review reports

Original Submission
19 Jun 2023	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
16 Aug 2023	Reviewed	Reviewer Report
21 Aug 2023	Reviewed	Reviewer Report
14 Sep 2023	Author responded	Author comments - Niklas Cyril Hansen
Resubmission - Version 3
14 Sep 2023	Submitted	Manuscript version 3
24 Sep 2023	Author responded	Author comments - Niklas Cyril Hansen
Resubmission - Version 4
24 Sep 2023	Submitted	Manuscript version 4
11 Oct 2023	Author responded	Author comments - Niklas Cyril Hansen
Resubmission - Version 5
11 Oct 2023	Submitted	Manuscript version 5
Publishing
14 Oct 2023	Editorially accepted
30 Oct 2023	Article published	10.1186/s12886-023-03177-9

Back to article page